コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 f ATP as well as AMP-PCP (a non-hydrolyzable ATP analog).
2 odulated by the polynucleotide substrate and ATP analog.
3 tivity to competitive inhibition via a bulky ATP analog.
4 analyzed to find an efficient unhydrolyzable ATP analog.
5 number in the presence of a nonhydrolyzable ATP analog.
6 tubule-attached, dimeric kinesin bound to an ATP analog.
7 benzoyladenosine, an irreversible inhibitory ATP analog.
8 trand with duplex DNA in the presence of the ATP analog.
9 lication of ATP but not by a nonhydrolyzable ATP analog.
10 nts containing AMPPNP, a slowly hydrolyzible ATP analog.
11 at the engineered v-Src uniquely accepted an ATP analog.
12 triphosphate, gamma-S-ATP, a nonhydrolyzable ATP analog.
13 ompassing all six subunits, upon binding the ATP analog.
14 receptor with AMPPNP, a hydrolysis-resistant ATP analog.
15 ed by binding of a specific non-hydrolyzable ATP analog.
16 nce of both phosphate and a non-hydrolysable ATP analog.
17 ce of added nucleotide or the presence of an ATP analog.
18 by another kinase that could not utilize the ATP analog.
19 and ssDNA in the presence and absence of an ATP analog.
20 as well as that bound to a non-hydrolyzable ATP analog.
21 ion showed intermediate sensitivity to these ATP analogs.
22 g studies using fluorescent and spin-labeled ATP analogs.
23 eriments and inhibition with nonhydrolyzable ATP analogs.
24 s in the presence of ATP and nonhydrolyzable ATP analogs.
25 ressed in the form of reductions in kcat for ATP analogs.
26 e obtained with either peptide inhibitors or ATP analogs.
27 th neutral-backbone DNA and non-hydrolyzable ATP analogs.
28 combination of peptide and non-hydrolysable ATP analogs.
29 changes in ternary complexes with different ATP analogs.
30 of the Pat1 kinase (pat1-as2) by adding the ATP analog 1-NM-PP1 in G1-arrested cells allows the indu
31 e required to activate the receptor, and the ATP analog 2',3'-O-(4-benzoyl-benzoyl)ATP (BzATP) is bot
32 Finally, we demonstrate that the fluorescent ATP analog 2'/3'-O-(N'-methylanthraniloyl)-ATP (mantATP)
34 ers in rigor were labeled with a fluorescent ATP analog, 3'-DEAC-propylenediamine (pda)-ATP (3'-O-{N-
36 nosine triphosphate, and the nonhydrolyzable ATP analog 5'-adenylyl-beta,gamma-imidodiphosphate (AMP-
37 presence and absence of the nonhydrolyzable ATP analog 5'-adenylyl-beta,gamma-imidodiphosphate (AMPP
38 Moreover, Top2 bound to the nonhydrolyzable ATP analog 5'-adenylyl-beta,gamma-imidodiphosphate exhib
39 ctivity in the presence of the non-substrate ATP analog 5'-adenylyl-beta,gamma-imidodiphosphate verif
41 iminated by substituting the nonhydrolyzable ATP analog 5-adenylyl-imidodiphosphate or UTP for ATP in
42 hydrolyze ATP, or to bind a nonhydrolysable ATP analog, 5'-adenylyl-beta,gamma-imidodiphosphate (ADP
46 mass spectrometry using a novel fluorescent ATP analog, 8-azido-ATP-[gamma]-1-naphthalenesulfonic ac
47 he presence and absence of a nonhydrolyzable ATP analog a catalytically incompetent TTM tunnel domain
49 in ternary complex with the nonhydrolyzable ATP analog adenosine 5'-(beta,gamma-imido)-triphosphate
50 oli PhoQ complexed with the non-hydrolyzable ATP analog adenosine 5'-(beta,gamma-imino)triphosphate a
52 ctivity is inhibited by the non-hydrolysable ATP analog (adenosine 5'-O-(thiotriphosphate)), T4 singl
55 h or without adenosine or a non-hydrolyzable ATP analog, adenosine 5'-(gamma-thio)-triphosphate (ATPg
56 structure, in complex with a nonhydrolyzable ATP analog, adenosine 5'-adenylyl-beta,gamma-imidodiphos
57 nding in the presence of the nonhydrolyzable ATP analog, adenosine 5'-O-(3-thio)triphosphate (ATPgamm
59 ants, L273A and L108A, and a nonhydrolyzable ATP analog, adenosine 5'-O-(3-thiotriphosphate) (ATPgamm
60 RepA in the presence of a poorly hydrolyzed ATP analog, adenosine 5'-O-(thiotriphosphate), and to re
62 nced upon the addition of a non-hydrolyzable ATP analog (adenylyl-imidophosphate), whereas ADP had no
65 Pase domain, bound with the non-hydrolyzable ATP analog ADP-beryllium fluoride, we studied the NtrC1-
67 ADP.Pi analogs ADP.AlF4 and ADP.Vi, and the ATP analogs ADP.BeFx, AMPPNP and ATPgammaNH2, all induce
71 hile in the presence of the non-hydrolyzable ATP analog, ADP-beryllium fluoride, we observe additiona
73 rate that the presence of a non-hydrolyzable ATP analog allows Mtr4p to discriminate between partial
74 mammalian cartilage and bone, the effects of ATP analogs, ALP substrates, and specific inhibitors on
75 trate (2S,5S)-5-carboxymethylproline (CMPr), ATP analog alpha,beta-methyleneadenosine 5'-triphosphate
77 ose homo-oligomers that are sensitive to the ATP analog alphabeta-methylene ATP(alphabetameATP) (P2X(
79 p did not catalyze the hydrolysis of ATP and ATP analogs, although fluorescence measurements indicate
80 f human BRAF(KD) in complex with MEK and the ATP analog AMP-PCP, revealing interactions between BRAF
81 e investigated whether interactions with the ATP analog AMP-PNP and ADP can shift the conformational
83 cellular perfusion with the non-hydrolyzable ATP analog AMP-PNP dramatically reduce the amplitude of
84 30 s, whereas those with the nonhydrolyzable ATP analog AMP-PNP had a mean lifetime of 4.8 +/- 0.7 mi
85 orylated, inactive state bound to either the ATP analog AMP-PNP or to one of the two small-molecule i
86 hondrial ATP, and cocrystallization with the ATP analog AMP-PNP suggests that binding of nucleotides
87 data establish that, in the presence of the ATP analog AMP-PNP, or ADP, a maximum of six DnaC monome
91 6p complexed with an RNA oligonucleotide and ATP analogs AMP-PNP, ADP-BeF(3)(-), or ADP-AlF(4)(-).
92 te (Vi), acetate, ATP, or a non-hydrolyzable ATP analog (AMP-PNP), with differential effects on matri
95 of the open state bound to a nonhydrolyzable ATP analog (AMPPCP) and 1,6-anhydroMurNAc provide detail
100 (CX3) X-ray co-crystal structure with bound ATP analog and define separable RAD51C replication stabi
101 e in a quaternary complex with tRNA(Gln), an ATP analog and glutamate reveals that the non-cognate am
102 f activated NTPDase3 with a non-hydrolyzable ATP analog and the cofactor Mg(2+) to a resolution of 2.
103 ed here, of bovine F1-ATPase inhibited by an ATP analog and the phosphate analog, thiophosphate, repr
106 rystal structures of Mss116p in complex with ATP analogs and single-stranded RNA show that the helica
110 microM in the presence of a nonhydrolyzable ATP analog, and 45 microM in the presence of ADP or no n
111 -adenylylimidodiphosphate, a nonhydrolyzable ATP analog, and was blocked in the presence of H7 or the
112 plants display protein kinase activity, bind ATP analogs, and possess C-terminal domains similar to b
113 ment formed on DNA in the presence of ATP or ATP analogs, and this has been studied at low-resolution
117 e intrinsic affinities of all of the studied ATP analogs are lower than the intrinsic affinities of t
118 , the detection of which can be modulated by ATP analogs as well as DNA sequence flanking the TATA se
119 ither a SMG1 inhibitor or a non-hydrolyzable ATP analog at overall resolutions ranging from 2.8 to 3.
123 ional changes in the loop that surrounds the ATP analog (ATP-lid) and has implications for interactio
124 We demonstrate that the nonhydrolyzable ATP analog, ATP gamma S, supports the formation of an is
125 we established the gamma-phosphate-modified ATP analog, ATP-biotin, as a cosubstrate for phosphorylb
126 he E. coli clamp-loader complex bound to the ATP analog ATPgammaS (at a resolution of 3.5 A) and ADP
128 addition of an excess of the unhydrolyzable ATP analog ATPgammaS, supplementation with exogenous ATP
133 his complex reveal that the non-hydrolyzable ATP analog, ATPgammaS, induces a high-affinity binding m
134 nucleotide, or in the presence of ADP or the ATP analog, ATPgammaS, there was no helical ordering.
136 unctional cycle by use of a non-hydrolyzable ATP analog, ATPgammaS, to mimic the ATP-bound GroEL stat
138 bound state as well as in complexes with the ATP analog beta-gamma-methylene adenosine triphosphate (
139 IC50 of inhibitors using the nonhydrolyzable ATP analog, beta, gamma-methyleneadenosine 5'-triphospha
142 e have previously shown that nonhydrolyzable ATP analogs block the lytic activity of NK cells and CD8
143 that binds ADP in bovine F(1) ATPase has an ATP analog bound and therefore this structure does not r
144 .ATP, and we observe a single molecule of an ATP analog bound in the aforementioned surface cavity, n
146 plex, deiNOS quenches the fluorescence of an ATP analog bound to TrpRS II, and increases its affinity
147 monomeric, AMP-PNP-DnaA (a non-hydrolysable ATP-analog bound-DnaA) was oligomeric, primarily dimeric
148 ences compared to AMPPNP (a non-hydrolyzable ATP analog) bound to PhoQcat and radicicol bound to Hsp9
149 ene)triphosphate (AMP-PCP) (non-hydrolyzable ATP analog) bound were also solved at 1.9-A resolution.
151 nzyl)-ATP and N(6)(phenethyl)-ATP over other ATP analogs, but still retained a 30 microm K(m) for ATP
154 n allostery not catalysis, and the classical ATP-analog class of tyrosine kinase inhibitors fail to i
156 e of magnesium and ATP (or a nonhydrolyzable ATP analog), contains maximal DNA helicase in the presen
158 (fluorosulfonyl)benzoyl]adenosine (FSBA), an ATP analog, demonstrate that both inhibitors bind to the
159 CW domains in complex with a nonhydrolyzable ATP analog demonstrates that the two domains are directl
163 wever, in the presence of a non-hydrolyzable ATP analog, DNA binding was only slightly compromised.
164 rom Dictyostelium in the presence of various ATP analogs do not show changes at the reactive thiol re
165 midodiphosphate (AMP-PNP), a nonhydrolyzable ATP analog, each kinesin-1 dimer binds two tubulin heter
167 pecific interactions with the adenine of the ATP analog, establishing the molecular basis of ATP reco
169 in, solved to 2.4 A both with and without an ATP analog, form isologous, but asymmetric homodimers.
171 olyzable (AMP-PNP, AMP-PCP) nor hydrolyzable ATP analogs (GTP, CTP, UTP, and ITP) activated hIK1.
173 e in complex with a peptide substrate and an ATP analog has been determined at 1.9 A resolution.
175 kinase domain and its binary complex with an ATP analog has revealed an identical open kinase conform
177 iphosphate (AMP-PNP), a hydrolysis-resistant ATP analog; however, this study mainly used AMP-PNP to f
178 iotic phosphate transfer system involving an ATP analog (imidazole phosphate) and histidyl peptides,
181 ormation when complexed with nonhydrolysable ATP analogs, in contrast to other transporter structures
185 e specifically sensitive to a cell-permeable ATP analog inhibitor, allowing us to perform high-resolu
189 Specifically, ATPgammaS (a nonhydrolyzable ATP analog) inhibits secretion of interferon gamma by NK
190 dominantly the P2X7 receptor (P2X7R), via an ATP analog initiate innate proinflammatory inflammation,
193 tegy, a neo-substrate approach involving the ATP analog kinetin triphosphate (KTP), can be used to in
197 ce microscope, we found that the fluorescent ATP analog methylanthraniloyl ATP (mantATP), which has b
201 nase displayed catalytic efficiency with the ATP analog, N(6)-(cyclopentyl) ATP, which is similar to
203 eport the PAICS structure with SAICAR and an ATP analog occupying the SAICAR synthetase active site.
207 the effects of ATP, ADP, and nonhydrolyzable ATP analogs on the lifetime of protein.DNA complexes.
209 ocked by the use of either a nonhydrolyzable ATP analog or a single-ring GroEL mutant, substrates com
210 ection from inhibition by a non-hydrolyzable ATP analog or acetylphosphate, in conjunction with the s
211 mplex with either APS and a non-hydrolyzable ATP analog or APS and sulfate revealed the overall struc
212 e enzyme is titrated with a non-hydrolyzable ATP analog or the enzyme is mutated such that it is able
213 hree structures of human ATP13A2 bound to an ATP analog or to spermine in the presence of phosphomime
214 n the presence of AMP-PNP (an unhydrolyzable ATP analog) or the autophosphorylation-site mutant, T267
215 ciated with ATPgammaS, a poorly hydrolyzable ATP analog, or ADP plus AlF(4), which mimics the transit
216 S, a nonphysiological and slowly hydrolyzed ATP analog, or by inactivating one of the two nucleotide
217 er with ATP-gamma-s, the slowly hydrolyzable ATP analog, or with ATP in the presence of alpha, beta-m
218 as observed with MgADP, with nonhydrolyzable ATP analogs, or with MgATP by catalytically inactive eny
219 diphosphate (AMPPNP), a hydrolysis-resistant ATP analog, prior to treatment with FSBMantAdo resulted
220 imidodiphosphate (AMPPNP), a nonhydrolyzable ATP analog, promotes stable complex formation between Re
221 bound to labeled RNA and a non-hydrolyzable ATP analog provide a direct view of how large domain mov
223 treatment with ATPgammaS, a nonhydrolyzable ATP analog, recapitulated early signaling events associa
224 tified using a combination of more selective ATP analogs, receptor expression studies, and study of d
226 eta,gamma-imidoadenosine 5'-triphosphate, an ATP analog, resolution 3.1 angstrom), ADP-P(i) (ADP with
227 versible in the presence of non-hydrolysable ATP analogs, resulting in a strong hyperpolarizing shift
228 omplex in the presence of a non-hydrolysable ATP analog reveal how nucleotide binding primes the comp
229 stal structure in the presence of Ca(2+) and ATP analog reveals a rotated headpiece, altered connecti
230 ty (5-8-fold) and binding of the 14C-labeled ATP analog rho-fluorosulfonylbenzoyl 5'-adenosine (FSBA)
234 horylation in receptor activation, and 4) an ATP analog selectively inhibits the GC-B mutants, indica
235 ntage of 3 different small molecules and the ATP-analog sensitive kinase allele technology to interce
237 To explore Ypk1/2 function, we constructed ATP analog-sensitive alleles of both kinases and monitor
239 nhibition of PKA catalytic subunits that are ATP analog-sensitive causes increased Bcy1 phosphorylati
244 3.8 A resolution) for this S1 complexed with ATP analogs, some of which are cross-linked by para-phen
246 normal function and disease, we developed an ATP analog-specific (AS) PKCdelta that is sensitive to s
247 -(benzyl) ATP to a cell lysate containing an ATP analog-specific kinase allele (as1 allele) results i
250 el is partly based on the reduced ability of ATP analogs such as adenosine 5'-(beta,gamma-imino)triph
252 Finally, experiments with non-hydrolyzable ATP analogs suggest that SpoIIIE can operate with non-co
253 netic and binding studies with a fluorescent ATP analog suggested that ATP induces a conformational c
254 ase, and binding analyses with a fluorescent ATP analog suggested unequal contributions by the two nu
255 inhibited by the addition of nonhydrolyzable ATP analogs, suggesting that ATP hydrolysis and not just
260 we show using two independent approaches--an ATP analog that can drive CFTR channel gating but is uns
261 nalysis the protective effect of AMP-PCP, an ATP analog that is not utilized for enzyme phosphorylati
262 s to be uniquely sensitive to inhibitors and ATP analogs that are not recognized by wild-type kinases
264 ns (unlike with assays utilizing radioactive ATP analogs), the assay described can be used to disting
269 In the presence of ATP or a nonhydrolyzable ATP analog, the initial step is the self-assembly of Clp
272 crystal structures in complexes with RNA and ATP analogs, Thomsen and Berger now elucidate the molecu
274 but not the wild type (WT) kinase, used the ATP analog to phosphorylate both a model peptide substra
275 Second, the binding of a nonhydrolyzable ATP analog to the yeast enzyme appears to affect citraco
277 tic resonance spectroscopy with spin-labeled ATP analogs to probe the structure of the ATP active sit
278 e kinetics of binding mantATP (a fluorescent ATP analog) to the microtubule K341 complex, the dissoci
280 pool also can be filled with the fluorescent ATP analog trinitrophenol ATP, as well as with a photoac
281 The 6-histidine loop bound the fluorescent ATP analog trinitrophenyl-ATP with high affinity, as det
282 bstrate, as well as spectroscopically active ATP analogs (trinitrophenyl-ATP and ATP gamma S-acetamid
283 circle in the presence of a nonhydrolyzable ATP analog under the same conditions that the wild type
284 rent activation in the presence of ATP or an ATP analog unsuitable for phosphotransfer, as well as ps
286 engineered to accept bulky N(6)-substituted ATP analogs, using a chemical genetics approach initiall
294 l-regulated kinase 2 (ERK2) that can utilize ATP analogs, we have identified the alternative mRNA spl
296 tructures of yeast dynein bound to different ATP analogs, which collectively provide insight into the
297 g by BLM in the presence of non-hydrolysable ATP analogs, which has implications for the underlying m
298 re fully bound to adenosine 5'-triphosphate (ATP) analogs, which is expected to induce opening of the
299 ased on their ability to bind a spin-labeled ATP analog with stoichiometries and equilibrium binding
300 erently in the presence of a nonhydrolyzable ATP analog, with subconductance openings significantly s